Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DiaMedica Therapeutics Inc DMAC

Healthcare Biotechnology
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in... see more

Bullboard (NDAQ:DMAC)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by joelouon Jan 27, 2019 8:36pm

Chart

Like how the chart is setting up ... looks like we are seeing the gaps being filled to the initial IPO of $4 US... about 500000 (on Nasdaq) shares of traded year to date .. not bad since the float has ...more  
133
Comment by Pandoraon Jan 24, 2019 10:27am

RE:RE:RE:For interest's sake

These guys seem to get a little better reaction to their news. Maybe it's our Canadian brand. vTv Therapeutics Inc. (VTVT) today announced the publication of a paper in Science Translational ...more  
112
Discussion
Comment by Pandoraon Jan 22, 2019 9:32am

RE:RE:For interest's sake

DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
73
Discussion
Post by TrueNorth911on Jan 21, 2019 5:50pm

HOLEY Getting Deep!

Hey Calgary Man, thought I'd save you the hassle and post your regular doom and gloom routine for you tonight... Jeepers Creepers, what are these guys doing to us?.....   OMG the SKY ...more  
106
Comment by Pandoraon Jan 20, 2019 11:36pm

RE:RE:RE:RE:RE:RE:RE:For interest's sake

Just noting that for our first day of trading only on the Nasdaq it just haens to be a U.S. holiday ---- here's to Tuesday.
88
Discussion
Comment by TrueNorth911on Jan 19, 2019 10:24am

RE:DEEP Hole

Dilution, yes, it happened, get over it. They are fully funded until end of phase II trials for both Stroke and CKD (starting imminently I think based on their filing...).  So, we're going ...more  
98
Discussion
Post by Roadster2on Jan 19, 2019 8:19am

DEEP Hole

Going towards end of January and no end in sight. Selling continues under offering price. This is all about dilution.
80
Discussion
Comment by TrueNorth911on Jan 18, 2019 4:29pm

RE:RE:RE:RE:RE:RE:For interest's sake

Good riddance.... crazy wild-west exchange.   Nasdaq has much more advanced trading recognition programs and alerts. You hear that Calgary Man?....... try your shenangins there, and expect ...more  
101
Discussion
Comment by Pandoraon Jan 18, 2019 10:32am

RE:RE:RE:RE:RE:For interest's sake

So today is the last day for V.DMA . Next week it will all be Nasdaq DMAC. Hopefully that turns out good.
61
Discussion
Comment by WesCoaston Jan 11, 2019 2:08pm

RE:RE:RE:RE:For interest's sake

Thanks for the clarification
72
Discussion
Comment by Pandoraon Jan 10, 2019 5:41pm

RE:RE:RE:For interest's sake

From my broker: -- "The DMA shares basically remain the same but will only trade as DMAC on the Nasdaq.   -- It does create a US component for you in the TFSA (which is allowed).  -- ...more  
135
Discussion
Comment by WesCoaston Jan 10, 2019 2:07pm

RE:RE:For interest's sake

So what does that mean? WIll our TSX shares be transfered to the Nasdaq?
64
Discussion
Comment by Pandoraon Jan 09, 2019 5:55pm

RE:For interest's sake

MINNEAPOLIS, Jan. 09, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) (TSX-V: DMA), a clinical stage biopharmaceutical company, announced today that it has applied to voluntarily ...more  
124
Discussion
Comment by Winnipeg40on Jan 08, 2019 12:32pm

RE:RE:RE:RE:RE:RE:RE:A very deep hole

Hopefully the picking off shares with a modest upwards bias continues....this is exactly as I expected after the Calgary dumper finished....Once Mgmt gets moving on a few more NR's and talking to ...more  
148
Discussion
Comment by Pandoraon Jan 03, 2019 8:54pm

RE:RE:RE:RE:The hole got deeper

I find when I have him on ignore I 'almost' don't see anything that he says.
58
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities